Approximately 55,100 new cases of prostate cancer are diagnosed every year in the UK
News
Endlyz Therapeutics emerges with pipeline for Parkinson’s disease
Research targets lysosomal function restoration for neurodegeneration
SMC approves bimekizumab for hidradenitis suppurativa treatment
The Scottish Medicines Consortium (SMC) has approved bimekizumab for adults with active moderate to severe...
European Commission approves ustekinumab for paediatric Crohn’s disease
Approval extends ustekinumab’s use to younger patients
Elekta and Azra AI partner to advance cancer registry operations with AI
Collaboration introduces automation to enhance efficiency
4basebio receives MHRA licence for synthetic DNA manufacture
GMP certification enables 4basebio to supply DNA for clinical trials
NICE recommends brentuximab vedotin plus AVD for Hodgkin lymphoma
Advancing care for stage 3 or 4 Hodgkin lymphoma patients
Diagnexia and Stratipath link up brings AI breast cancer diagnostics to UK
Collaboration expands AI-based risk profiling tools
Genome editing offers hope for genetic hearing loss
New therapy developed to repair GJB2 R75W mutation
Amivantamab plus lazertinib shows survival benefit in lung cancer
Janssen drug combination extends life expectancy during trial
Nouscom reveals promising results for lynch syndrome immunotherapy
NOUS-209 shows potential to intercept cancer in its early stages
WHO adds first maternal RSV vaccine to prequalification list
Pfizer’s Abrysvo is designed to prevent RSV-associated disease in infants
UK expands mandatory infectious disease reporting requirements
The update is aimed at strengthening local and national surveillance
Orca Bio’s T-cell therapy shows promise in haematological malignancies
The company is preparing to submit the results to the FDA this year
UKHSA announces new effort to tackle hepatitis C
The agency has launched a whole genome sequencing service to monitor the virus
